BNET Industries

Pozen Inc.

(POZN) is in the Pharma Industry

Market Cap:$169.1M
Last Fiscal Year Sales:$66.1M
  • Public
  • US
Dow Jones Description

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. With fewer than 40 employees, POZEN is focused in the pain area of innovative drug development and in creating strategic, high-value partnerships with larger pharmaceutical companies for the commercialization of the company's drug candidates.

President, CEO and Chairman
John R. Plachetka
Number of Employees 34
Contact Information

1414 Raleigh Rd Ste 400

Chapel Hill, North Carolina 27517-8834

pozen.com

(919) 913-1030

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Pozen hits on profit, misses on revenue

    10/28/09 - Joint Venture / Alliance - View Story

  • POZEN Reports Third Quarter 2009 Results

    10/28/09 - Mgmt. Change Entering - Vice President - View Story

  • Pozen looks to focus on commercialization [The Herald-Sun, Durham, N.C.]

    10/29/09 - Financial Announcement - View Story

  • POZEN Names Elizabeth A. Cermak as Executive Vice President,

    9/14/09 - Mgmt. Change Entering - Vice President - View Story

  • POZEN Announces July 28, 2009 Webcast of Second Quarter 2009 Results

    7/14/09 - Financial Announcement - View Story

  • Uphill battle for migraine drug

    6/23/09 - Licensing / Contract - View Story

News & Analysis

finance and pozen inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
John G. Fort Chief Medical Officer
William L. Hodges Senior Vice President Finance & Administration and Chief Financial Officer
Everadus Orlemans Senior Vice President, Product Development
Gilda M. Thomas Senior Vice President
James Alexander senior vice president, product
Kristina M Adomonis Senior Vice President, Business Development
John E. Barnhardt Vice President, Finance and Administration and Principal Accounting Officer
Fran Barsky Director, Ir
Helga L Leftwich Secretary
Kenneth B. Lee Jr. Director

Board of Directors

Name (plus bio) Position
John R. Plachetka President, CEO and Chairman
Arthur S. Kirsch Chairman
Bruce A. Tomason Chairman
Jacques F. Rejeange Chairman
James J. Mauzey Board of Directors
Joseph Mauzey James Board of Directors
Paul J. Rizzo Board of Directors
Peter J. Wise Co-Founder, Director and Vice Chairman of the Board of Directors

Organization Position Status
POZEN, Inc. President, CEO and Chairman Current
POZEN, Inc. Founder Current
The University of Arizona Assistant Professor of Pharmacy Practice Former
University of Missouri-Kansas City doctor of pharmacy degree Former
University of Missouri-Kansas City Degree Former

Organization Position Status
POZEN, Inc. Chief Medical Officer Current
Pharmacia Corporation Vice President, Arthritis and Pain Former
Adolor Corporation Vice President, Medical Affairs Former
Thomas Jefferson University Associate Prof of Medicine Former

Organization Position Status
POZEN, Inc. Senior Vice President Finance & Administration and Chief Financial Officer Current
The Crosland Group Inc. Managing Director Current
POZEN, Inc. Board of Directors Current
Pergo AB chief financial officer Former
Pergo AB senior vice president Former
Banc of America Securities LLC head of Debt Capital Markets Former
Burroughs Wellcome Co. - USA Former
Georgia State University master's degree in finance Former
The University of North Carolina at Chapel Hill Bachelor's Degree In Business Administration, Accounting Former
The University of North Carolina at Chapel Hill Batchelor's Degree in Business Administration, Accounting Former

Organization Position Status
POZEN, Inc. Senior Vice President, Product Development Current

Organization Position Status
POZEN, Inc. Senior Vice President Current
EMD Lexigen Research Center Corp. General Counsel & Vice President Current
POZEN, Inc. General Counsel Current
POZEN, Inc. Board of Directors Current
Emd Pharmaceuticals, Inc. Vice President Former
Emd Pharmaceuticals, Inc. General Counsel Former
Burroughs Wellcome Co. - USA Former
Emd Pharmaceuticals, Inc. Board of Directors Former
Harvard Law School Juris Doctor Degree Former
Simmons College Masters' Degree Former
Wellesley College Bachelor's Degree Former

Organization Position Status
POZEN, Inc. senior vice president, product Current
The University of Mississippi M.D. Former
University of Mississippi M.D. Former
The University of Alabama at Birmingham M.P.H. Former

Organization Position Status
POZEN, Inc. Senior Vice President, Business Development Current
Over-The-Counter.Com Vice President of Global Business Development and Licensing Former
McGill University MBA Former
Tufts University Bachelor's Degree In Chemistry Former

Organization Position Status
POZEN, Inc. Vice President, Finance and Administration and Principal Accounting Officer Current
POZEN, Inc. Board of Directors Current
Medco Research, Inc. chief financial officer Former
North Carolina State University Bachelor's Degree In Zoology Former
North Carolina State University Batchelor's Degree in Zoology Former

Organization Position Status
POZEN, Inc. Director, Ir Current

Arthur Kirsch is a Managing Director with Savvian, focusing on the Healthcare sector. He has 31 years of investment banking / capital markets experience, in a broad range of capacities. Prior to Savvian, Arthur was a Managing Director at Vector Securities and held senior management positions at Natwest Securities, and Drexel Burnham Lambert. He received his BS from the University of Rhode Island and his MBA from Baruch College.

Organization Position Status
Savvian LLC Managing Director Current
Vector Securities Managing Director Current
POZEN, Inc. Chairman Current
Vector Corporation Former
POZEN, Inc. Board of Directors Former
Baruch College MBA Former

Organization Position Status
Alterna Chief Executive Officer Current
POZEN, Inc. Chairman Current
One Call Medical, Inc. Chief Executive Officer Former
One Call Medical, Inc. President Former
Evans Medical Inc. Vice President Former
The Corporate Development Company Manager Former
POZEN, Inc. Board of Directors Current

Mr. Jacques Rejeange joined the board of directors of POZEN in February of 2007 and is a member of the nominating/corporate governance committee. Mr. Rejeange was previously appointed to the POZEN Board of Directors in April 1997 and served as Chairman of the Board of Directors from December 1999 to December 2000 before his retirement in 2004. He currently sits on the Boards of Medicentrix AG and Swisslog AG in Switzerland. Previously, Mr. Rejeange was President of Florham Consulting S.A. based in Areuse, Switzerland; Chief Operating Officer and later President and Chief Executive Officer of Sterling Winthrop, Inc.; and President and Chief Executive Officer of Sandoz Pharmaceuticals Corporation USA.

Organization Position Status
POZEN, Inc. Chairman Current
POZEN, Inc. Board of Directors Current

Organization Position Status
POZEN, Inc. Secretary Current

Mr. James J. Mauzey joined the board of directors in May 2006 and is the chairman of the compensation committee. Mr. Mauzey has over 30 years experience in the pharmaceutical industry. He was formerly president and chief executive officer of Bertek Pharmaceuticals, Inc, a division of Mylan Laboratories, Inc. Prior to that, he was chief executive officer of Innovex Worldwide, the contract sales division of Quintiles Transnational Organization and chairman and chief executive officer of Alteon Inc. In addition, Mr. Mauzey has held numerous sales, marketing and executive positions with Lederle Laboratories and Bristol-Myers Squibb Company. Mr. Mauzey received a bachelor's degree from Lewis University and an MBA from Xavier University.

Organization Position Status
POZEN, Inc. Board of Directors Current
Bertek Pharmaceuticals Inc Chief Executive Officer Former
Bertek Pharmaceuticals Inc President Former
Lederle Laboratories Former
Bristol-Myers Squibb Company Former
Xavier University MBA Former
Lewis University Bachelor's Degree Former

Organization Position Status
POZEN, Inc. Board of Directors Current

Ken is co-founder of Hatteras Venture Partners II and former co-head of the International Life Science Practice at Ernst & Young; He is currently Chairman of Inspire Pharmaceuticals, and a member of the boards of OSI Pharmaceuticals, CV Therapeutics and Pozen.

Organization Position Status
Hatteras Venture Partners Co-Founder Current
N.C. Bioscience General Partner, Hatteras Biocapital, Llc Current
Ranexa General Partner of Hatteras Biocapital Current
Hatteras Biocapital, LLC General Partner Current
Lifeheart.Com General Partner of Hatteras Biocapital Current
OSI Pharmaceuticals, Inc. Certified Public Accountant Current
Inspire Pharmaceuticals, Inc. Chair of Board Current
OSI Pharmaceuticals, Inc. Board of Directors Current
Ranexa Director Current
POZEN, Inc. Director Current
Amgen Fremont Board of Directors Current
CV Therapeutics Inc. Board of Directors Current
Lifeheart.Com Director Current
N.C. Bioscience Board of Directors Current
Hatteras Biocapital, LLC Managing Member Current
A. M. Pappas & Associates President Former
Hatteras Venture Partners General Partner Former
Ernst & Young partner Former
Young Corporation Director of The Life Science Practice Former
The University of North Carolina at Chapel Hill MBA Former
Lenoir-Rhyne College Bachelor of Arts Degree Former

Organization Position Status
Franklin Street Partners Partner Current
Oberlin Capital, L.P. Principal Current
Geomagic, Inc. Current
Franklin Street Partners Chairman Current
Aris Partners LLC Chairman of Franklin Street Partners Current
Cox Enterprises, Inc. Board of Directors Current
Maersk Inc. Board of Directors Current
POZEN, Inc. Board of Directors Current
International Business Machines Corporation Vice Chairman Former
Johnson & Johnson Director Former
Morgan Stanley Director Former
McGraw Hill Director Former
The University of North Carolina at Chapel Hill Bachelor's Degree In Commerce Former

Organization Position Status
POZEN, Inc. Co-Founder, Director and Vice Chairman of the Board of Directors Current
POZEN, Inc. Board of Directors Current
Pharmaceutical Product Development, Inc. President Former
Pharmaceutical Product Development, Inc. Chief Operating Officer Former
advertisement
     POZN $5.67 +0.09 (1.61% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 101,274
Shares Outstanding 29.83M
Market Cap 169.1M
Year High 8.42
Year Low 4.5
Earnings Per Share -0.18
P/E Ratio -31.50
Dividend N/A
Yield N/A
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement
Click Here
Presented by American Express